Integrated
Global Innovation
Based in Cambridge, MA, Novastra Therapeutics operates a unified,
high-velocity operating model designed to accelerate the path from discovery to cure.
Integrated Global Innovation Engine
Innovation requires specific rigor and speed.
Our Integrated Global Innovation Engine seamlessly combines strategic leadership with high-throughput clinical execution. This unified structure enables us to generate rigorous, regulatory-compliant human data with exceptional speed, adhering strictly to ICH-GCP standards without geographical boundaries. We leverage global efficiencies to advance rapid proof-of-concept in the most challenging clinical settings.
A System-Level Reset
We founded Novastra to move beyond treating cancer lesion by lesion. Our vision is to reprogram the patient's immune system systematically.
By turning the patient's own cancer into a precision immunotherapy, we aim to provide durable
outcomes for those who have exhausted standard options.